TARIS Biomedical adds Kevin Finney and Mark Iwicki to its Board and raises $32m financing led by Flagship Ventures

– USA, MA – TARIS Biomedical LLC, a company using proprietary delivery technology and deep expertise in bladder biology to develop novel treatments for urologic diseases, announced today it has relaunched with a $32 million financing led by Flagship Ventures with participation from return investor Polaris Venture Partners and new investor RA Capital Management.…